reference/28432119

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/28432119

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	925
issn	2326-6074 2326-6066
issueIdentifier	7
pageRange	912-925
publicationName	Cancer Immunology Research
startingPage	912
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_8090b0b1714934d63b624f521cfa3f5c http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_198be1621a05a7b6382d2ec966c36982 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1d87a6c3b25210f0fba35c4abf5159b
bibliographicCitation	Jin HS, Ko M, Choi DS, Kim JH, Lee DH, Kang SH, Kim I, Lee HJ, Choi EK, Kim KP, Yoo C, Park Y. CD226hiCD8+ T Cells Are a Prerequisite for Anti-TIGIT Immunotherapy. Cancer Immunol Res. 2020 Jul;8(7):912–25. doi: 10.1158/2326-6066.cir-19-0877. PMID: 32265229.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1314-7952 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3186-3488 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_897632c8ef5dc892260e532e662ec659 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d4ecff276851fce83335ca10179bf0c0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_127abe752a2f40cb929907435f2b33d2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cc882b31bb7a26e85a9b72627d7d4001 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2461-3915 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b7d52b38304efba46a6146753f94c9ee http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_07a6442650964f8e208407428ad5a904 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0871-8901 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9353737e9e0e4f65c94edf5b88abc713 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_642996b048a6c2c5b3c5c6474ff9ebeb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_74d4c104acfd036d6b041b57bdb9091c
date	2020-07-01^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1158/2326-6066.cir-19-0877 https://pubmed.ncbi.nlm.nih.gov/32265229
isPartOf	https://portal.issn.org/resource/ISSN/2326-6066 https://portal.issn.org/resource/ISSN/2326-6074 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/41946
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	CD226hiCD8+ T Cells Are a Prerequisite for Anti-TIGIT Immunotherapy
discusses	http://id.nlm.nih.gov/mesh/M0022149 http://id.nlm.nih.gov/mesh/M0001415 http://id.nlm.nih.gov/mesh/M0281032 http://id.nlm.nih.gov/mesh/M0528992 http://id.nlm.nih.gov/mesh/M000626416 http://id.nlm.nih.gov/mesh/M0018602
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D011971Q000037 http://id.nlm.nih.gov/mesh/D018414Q000276 http://id.nlm.nih.gov/mesh/D011971Q000276 http://id.nlm.nih.gov/mesh/D007167Q000379 http://id.nlm.nih.gov/mesh/D000074322Q000494 http://id.nlm.nih.gov/mesh/D009369Q000628
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D009369Q000276 http://id.nlm.nih.gov/mesh/D018414Q000378 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D000945Q000378 http://id.nlm.nih.gov/mesh/D004195 http://id.nlm.nih.gov/mesh/D000945Q000276 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D014408Q000276 http://id.nlm.nih.gov/mesh/D008810 http://id.nlm.nih.gov/mesh/D008807 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D014408Q000378 http://id.nlm.nih.gov/mesh/D009369Q000378
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c1da861a271010c66f326fc0e7473dbb http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_29f84c0d894769b14b36c5f43f54153e http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6795 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7706 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6057 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7fb951142eb6c03b505d06253e135a20

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID10666

Showing number of triples: 1 to 70 of 70.